The Next Generation TOF-monitor. The arm can be tucked under surgical drapes, no thumb access required. Less than 30s start-up, no calibration needed. Ease of use, with single-use electrosensors and no cross-contamination. Precise and reliable information based on EMG-technique. Awaiting FDA Approval. Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The company's shares are listed on Nasdaq First North (ticker SEZI)
Copyright 2016, a2z, Inc. All rights reserved.